Teleflex, Inc. (TFX)
124.12
-1.99
(-1.58%)
USD |
NYSE |
Oct 02, 16:00
124.16
+0.04
(+0.03%)
Pre-Market: 20:00
Teleflex Net Income (Quarterly) : 41.76M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.76M |
| March 31, 2026 | -4.838M |
| December 31, 2025 | -3.552M |
| September 30, 2025 | -408.88M |
| June 30, 2025 | 68.18M |
| March 31, 2025 | 52.33M |
| December 31, 2024 | 35.89M |
| September 30, 2024 | 110.92M |
| June 30, 2024 | 80.16M |
| March 31, 2024 | 15.74M |
| December 31, 2023 | 31.18M |
| September 30, 2023 | 137.67M |
| June 30, 2023 | 111.42M |
| March 31, 2023 | 77.30M |
| December 31, 2022 | 78.11M |
| September 30, 2022 | 101.88M |
| June 30, 2022 | 105.56M |
| March 31, 2022 | 77.37M |
| December 31, 2021 | 127.46M |
| September 30, 2021 | 199.51M |
| June 30, 2021 | 83.28M |
| March 31, 2021 | 74.87M |
| December 31, 2020 | 76.60M |
| September 30, 2020 | 116.60M |
| June 30, 2020 | 11.44M |
| Date | Value |
|---|---|
| March 31, 2020 | 131.15M |
| December 31, 2019 | 107.81M |
| September 30, 2019 | 228.93M |
| June 30, 2019 | 83.33M |
| March 31, 2019 | 41.92M |
| December 31, 2018 | 87.51M |
| September 30, 2018 | 56.54M |
| June 30, 2018 | -2.552M |
| March 31, 2018 | 54.93M |
| December 31, 2017 | -42.85M |
| September 30, 2017 | 79.40M |
| June 30, 2017 | 78.36M |
| March 31, 2017 | 40.35M |
| December 31, 2016 | 60.88M |
| September 30, 2016 | 66.20M |
| June 30, 2016 | 59.40M |
| March 31, 2016 | 51.18M |
| December 31, 2015 | 90.76M |
| September 30, 2015 | 61.57M |
| June 30, 2015 | 45.20M |
| March 31, 2015 | 39.27M |
| December 31, 2014 | 52.13M |
| September 30, 2014 | 55.23M |
| June 30, 2014 | 48.83M |
| March 31, 2014 | 35.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 151.57M |
| Veracyte, Inc. | 25.49M |
| Penumbra, Inc. | 34.81M |
| IDEXX Laboratories, Inc. | 338.41M |
| Alphatec Holdings, Inc. | -25.78M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 570.33M |
| Total Expenses (Quarterly) | 528.57M |
| EPS Diluted (Quarterly) | 2.283 |
| Enterprise Value | 7.817B |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 7.32% |
| Earnings Yield | -18.77% |
| Operating Earnings Yield | 5.23% |
| Normalized Earnings Yield | -11.35 |